Cancer Research Landon Prizes for Basic and Translational Cancer Research  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manfredi, J. J.
Right arrow Articles by Aaronson, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manfredi, J. J.
Right arrow Articles by Aaronson, S. A.
[Cancer Research 65, 2602-2609, April 1, 2005]
© 2005 American Association for Cancer Research


Molecular Biology, Pathobiology, and Genetics

Evidence against a Role for SV40 in Human Mesothelioma

James J. Manfredi1, Jianli Dong1, Wen-jun Liu1, Lois Resnick-Silverman1, Rui Qiao1, Philippe Chahinian1, Marko Saric3, Allen R. Gibbs4, James I. Phillips5, J. Murray5, Charles W. Axten2, Robert P. Nolan2 and Stuart A. Aaronson1

1 Department of Oncological Sciences, Mount Sinai School of Medicine; 2 Center for Applied Studies of The Environment and Earth and Environmental Sciences of the Graduate School and University Center of The City University of New York, New York, New York; 3 Institute for Medical Research and Occupational Health, Zagreb, Croatia; 4 Llandough Hospital, Pernarth, United Kingdom; and 5 National Institute for Occupational Health and the School of Public Health, University of Witswatersrand, Johannesburg, Republic of South Africa

Requests for reprints: Stuart A. Aaronson, Mt. Sinai Medical Center, One Gustave Levy Place, New York, NY 10020. Phone: 212-659-5400; Fax: 212-987-2240; E-mail: stuart.aaronson{at}mssm.edu.

SV40 has been implicated in the etiology of 40% to 60% of human mesotheliomas. These studies could have important medical implications concerning possible sources of human infection and potential therapies if human tumors are induced by this agent. We did PCR-based analysis to detect SV40 large T antigen DNA in human mesotheliomas. None of 69 tumors in which a single copy gene was readily amplified contained detectable SV40 large T antigen sequences. Under these conditions, it was possible to detect one copy of integrated SV40 DNA per cell in a mixture containing a 5,000-fold excess of normal cells using formalin-fixed preparations. Kidney, a known reservoir of SV40 in monkeys, from some of these individuals were also negative for SV40 large T antigen sequences. A subset of mesotheliomas was analyzed for SV40 large T antigen expression by immunostaining with a highly specific SV40 antibody. These tumors as well as several human mesothelioma cell lines previously reported to contain SV40 large T antigen were negative for detection of the virally encoded oncoprotein. Moreover, mesothelioma cell lines with wild-type p53 showed normal p53 function in response to genotoxic stress, findings inconsistent with p53 inactivation by the putative presence of SV40 large T antigen. Taken together, these findings strongly argue against a role of SV40 by any known transformation mechanism in the etiology of the majority of human malignant mesotheliomas.

Key Words: mesothelioma • SV40 • large T antigen • p53 • DNA tumor viruses




This article has been cited by other articles:


Home page
ThoraxHome page
British Thoracic Society Standards of Care Committ
BTS statement on malignant mesothelioma in the UK, 2007
Thorax, November 1, 2007; 62(Suppl_2): ii1 - ii19.
[Full Text] [PDF]


Home page
JCOHome page
D. L. Poulin and J. A. DeCaprio
Is There a Role for SV40 in Human Cancer?
J. Clin. Oncol., September 10, 2006; 24(26): 4356 - 4365.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
K. S. Rosenthal and D. H. Zimmerman
Vaccines: all things considered.
Clin. Vaccine Immunol., August 1, 2006; 13(8): 821 - 829.
[Full Text] [PDF]


Home page
NEJMHome page
L. Pantanowitz, C. N. Otis, A. Munoz, R. Barcelo, G. Lopez-Vivanco, F. Lopez-Rios, M. Ladanyi, B. W.S. Robinson, and R. A. Lake
Malignant Mesothelioma
N. Engl. J. Med., January 19, 2006; 354(3): 305 - 307.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.